Noble Pharma, LLC

Form 483 issued March 6, 2025 · Menomonie, Wisconsin

Inspection
Nov 22, 2024 – Mar 6, 2025
Investigator
Chase S. Baldwin
Observations
2
Pages
14
FEI number
3009771624

In short: On March 6, 2025, FDA issued a Form 483 with 2 observations to Noble Pharma, LLC in Menomonie, Wisconsin (FEI 3009771624) after an inspection that ran Nov 22, 2024 – Mar 6, 2025. The investigator was Chase S. Baldwin. Most observations concern food CGMP / preventive controls; the most-cited regulation is 21 CFR 117.35 (sanitary operations).

At a glance

2 of 2 observations on this 483 concern food cgmp / preventive controls.

Food CGMP / preventive controls2

Most cited: 21 CFR 117.35 (1×) · 117.37 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    You did not ensure that your cleaning compounds and sanitizing agents are safe and adequate under…

  2. 02

    Your plant did not have adequate…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Noble Pharma, LLC?

FDA listed 2 observations on this Form 483, mostly about food CGMP / preventive controls. The most-cited regulation is 21 CFR 117.35 (sanitary operations). The opening words of each observation are shown on this page.

Who inspected Noble Pharma, LLC?

Chase S. Baldwin is named on this Form 483, for the inspection of Nov 22, 2024 – Mar 6, 2025. Each investigator has a profile showing what they cite most.

When was Noble Pharma, LLC inspected by FDA?

The inspection ran Nov 22, 2024 – Mar 6, 2025, and the Form 483 is dated March 6, 2025.

How do I get the full Form 483 for Noble Pharma, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free